Microarrays Research - Experiments, Designs, Statistics, Analysis, Software

Microarrays Research Today is a free monthly online journal that collates and summarizes the latest research about Microarrays, including details on experiments, designs, statistics, analysis, software.


Microarrays Research Today

Home

View Latest Issue

Information About Microarrays

Books on Microarrays

Advertising in Research Today

View Other Research Today Publications



Microarray analysis of Cryphonectria parasitica Galpha- and Gbetagamma-signalling pathways reveals extensive modulation by hypovirus infection.

Dawe AL, Segers GC, Allen TD, McMains VC, Nuss DL

Center for Biosystems Research, University of Maryland Biotechnology Institute, 5115 Plant Sciences Building 036, College Park, MD 20742, USA.

Using an established spotted cDNA microarray platform, the nature of changes in the transcriptional profiles of 2200 unique genes from the chestnut blight fungus Cryphonectria parasitica in response to the absence of either the Galpha subunit CPG-1 or the Gbeta subunit CPGB-1 has been explored. It is reported that 216 transcripts were altered in accumulation in the Deltacpg-1 strain and 163 in the Deltacpgb-1 strain, with a considerable overlap (100 genes) that were changed in both cases. Of note, these commonly altered transcripts were changed in the same direction in every instance, thus suggesting a considerable redundancy in pathway control or extensive crosstalk. To further knowledge of the potential impact on G-protein-signalling of infection by hypovirus CHV1-EP713, the accumulation of CPG-1 and CPGB-1 was also investigated by Western analysis. It was demonstrated that both signalling components were reduced in abundance to approximately 25 % of wild-type levels, while their transcripts were slightly elevated. Comparison of a list of genes with altered expression in the presence of CHV1-EP713 to the data obtained in the absence of either G-protein subunit showed that more than one-half of all the transcripts changed by hypovirus infection were also changed in at least one G-protein mutant strain, with one-third being changed in both. Significantly, 95 % of the co-changed genes were altered in the same direction. These data provide the first evidence for modulation of Gbeta protein levels as well as the Gbetagamma-signalling pathways by hypovirus infection, and support the hypothesis that modification of G-protein-signalling via both Galpha and Gbetagamma provides for a significant contribution to hypovirus-mediated phenotype.

Published 7 December 2004 in Microbiology, 150: 4033-43.
Full-text of this article is available online (may require subscription).

Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Microarrays Research Today. All Rights Reserved.



Microarrays Research Today Archive:

Volume 1 (2004)
  Issue 1 (June)
  Issue 2 (July)
  Issue 3 (August)
  Issue 4 (September)
  Issue 5 (October)
  Issue 6 (November)
  Issue 7 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)



Microarrays Books

Bioinformatics in Cancer and Cancer Therapy (Cancer Drug Discovery and Development)

Bioinformatics in Cancer and Cancer Therapy (Cancer Drug Discovery and Development)